Track record · closed signal

CareTrust REIT, Inc. (CTRE) — closed signal from October 23, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on January 21, 2026.

Predicted vs. what happened

CTRE price · publication thesis → realized outcomesplit-adjusted
$34.70 Published $37.83 Target $37.39 Window close $38.23 Peak
$33.88 – $34.86Entry zone — fair-value band
$34.70Published — price the day we called it
$37.83Target — the price the thesis aimed for
$38.23Peak — highest point inside the window, not a realized return
$37.39Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 78 days.

Peak price
$38.23
peak on January 9, 2026 — not a realized return
Peak gain
+10.2%
peak, from the publication price
Window close
$37.39
end-of-window price, context only
Days to target
78
Window
October 23, 2025 – January 21, 2026

The thesis — published October 23, 2025

Predicted growth
+10%
over the measurement window
Target price
$37.83
the price the thesis aimed for
Entry zone
$33.88 – $34.86
the fair-value band we waited for
Price at publication
$34.70
published October 23, 2025
Confidence
68%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

CareTrust REIT aims to deliver steady income with gradual growth. Recent updates show new care facility purchases in the UK and 10 straight years of dividend increases. Analysts think it could reach about $37.5. The price trend looks healthier, with lots more people buying than usual. In uncertain markets, investors often favor steadier businesses, and this stock usually moves less than the market.

Primary drivers

  • A decade of dividend raises signals reliable income and disciplined management.
  • Buying UK care sites adds properties and broadens where it earns money.
  • Price trend turning up, with lots more people buying than usual.
  • Analysts see about $37.5 as fair value, suggesting moderate upside.

How it played out

CTRE: target reached in 78 days

Lyra published CTRE at $34.70 on 2025-10-23, with expected growth of 10% over the short-term window. The thesis pointed to steady income, 10 straight years of dividend increases, UK care facility purchases, a healthier price trend, unusually heavy buying, lower market sensitivity, and analyst fair value near $37.5.

Inside the window, CTRE rose to a peak of $38.23 on 2026-01-09. That was above the $37.83 target, and the peak gain was 10.2%. The target was reached in 78 days. By 2026-01-21, it ended at $37.39. The thesis played out.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.